IP Library Granted Patent US 9,592,354
Granted Patent B2
US 9,592,354 · App. 13/191,315 · Granted Mar 14, 2017

Combination unit dose dispensing containers

Inventors: Timothy R. Sullivan (Cedar Park, TX); Jeffrey Nelson (Round Rock, TX)
Assignee: Mystic Pharmaceuticals, Inc.
A61M15/0028A61M15/0031A61M15/0036A61M15/0051A61M15/0061A61M35/003A61F9/0008A61J1/067A61J1/2024A61J1/2027A61M15/003A61M2202/064
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,592,354
App. No.
13/191,315
Granted
Mar 14, 2017
Kind
B2
Abstract

Dosage forms containing pharmaceutical compositions for use in devices to produce a spray or mist delivery of the compositions include dosage blister compartments and a dispensing blister compartment, wherein crushing of the compartments delivers the compositions in a desired spray pattern. Certain dosage forms include a plurality of dosage chambers each containing a component or a portion of a pharmaceutical composition, the contents of which are mixed or combined just prior to or during administration.

Claims (12)

1. An internally pierced formed blister comprising:

a blister formed from a stretched flexible film material into a recess with an open end;

a piercable surface sealed to the open end of the blister to form an internal chamber enclosed by the formed recess; and

a piercing nozzle wholly contained in the internal chamber, the piercing nozzle comprising a base, a tapered hollow elongated body, projecting from the base at a first end, and forming an internal channel and a discharge nozzle at a second end opposite the base, and comprising structural features on the surface of the internal channel to control the spray pattern and droplet size of a fluid forced to flow through the piercing nozzle under pressure, and one or more inlet openings and channels providing a fluid path from the internal chamber through the base and into the internal channel of the piercing nozzle and out the discharge nozzle.

2. The internally pierced formed blister of claim 1 , wherein the structural features include contours, steps, flutes, ribs, constrictions, or a combination thereof.

3. The internally pierced formed blister of claim 1 , wherein the fluid path from the internal chamber into the internal channel comprises one or more bends.

4. The internally pierced formed blister of claim 3 , wherein the one or more bends include at least one 90° bend.

5. The internally pierced formed blister of claim 1 , wherein the fluid path and structural features produce a vortex in fluids forced through the piercing nozzle under pressure.

6. The internally pierced formed blister of claim 1 , wherein the piercing nozzle is held in position in the internal chamber by a close fit of the base with the shape of the recess opposite the piercable surface and wherein the position includes the discharge nozzle proximate the piercable surface.

7. The internally pierced formed blister of claim 1 , further comprising a liquid or powdered composition contained in the internal chamber.

8. The internally pierced formed blister of claim 7 , wherein the composition and the internal chamber are sterile.

9. The internally pierced formed blister of claim 7 , wherein the composition is a medical composition.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2024
From: MYSTIC PHARMACEUTICALS, INC.
To: INFUSE, LLC
Reel/Frame 067218/0332 →
Continuity (5)
Continuation 12694849 · Jan 27, 2010
Division 12121644 · May 15, 2008
Provisional Application 60938379 · May 16, 2007
Provisional Application 60978619 · Oct 9, 2007
Related Publication 20110277763A1 · Nov 17, 2011